Bank of New York Mellon Corp - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 46 filers reported holding OMEGA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$156,119
-61.6%
72,613
-0.0%
0.00%
Q2 2023$406,750
+551.6%
72,634
+601.6%
0.00%
Q1 2023$62,423
-37.6%
10,352
-40.9%
0.00%
Q4 2022$100,050
-70.9%
17,522
-68.3%
0.00%
Q1 2022$344,000
+97.7%
55,277
+260.3%
0.00%
Q4 2021$174,000
-28.7%
15,343
+18.6%
0.00%
Q3 2021$244,00012,9380.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$6,653,0008.31%
CHI Advisors LLC 1,055,882$19,904,0005.81%
Flagship Pioneering Inc. 25,902,269$488,258,0005.11%
HARBOURVEST PARTNERS LLC 2,647,059$49,897,0004.69%
Octagon Capital Advisors LP 370,279$6,980,0001.72%
Monashee Investment Management LLC 441,176$8,316,0001.54%
Artal Group S.A. 2,273,530$42,856,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 527,948$9,952,0000.84%
PLATINUM INVESTMENT MANAGEMENT LTD 500,000$9,425,0000.26%
Logos Global Management LP 88,235$1,663,0000.12%
View complete list of OMEGA THERAPEUTICS INC shareholders